Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
AJAdrianus J. de LangenMLMelissa L. JohnsonJMJulien MazièresACAnne‐Marie C. DingemansGMGiannis Mountzios
Dutch Cancer Society · The Netherlands Cancer Institute · +32 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
551
total citations
- FWCI
- 132.64
- Percentile
- 100%
- References
- 30
Citations per year
Authors
32Topics & keywords
Topics
Keywords
- Docetaxel
- Medicine
- Internal medicine
- Oncology
- Lung cancer
- Cancer
- Taxane
- Progressive disease
No related works found for this paper.